This link will take you to a Web site maintained by a third party who is solely responsible for its contents. ARIAD Pharmaceuticals, Inc. and Merck & Co., Inc. provide this link as a service to Web site visitors. ARIAD Pharmaceuticals, Inc. and Merck & Co., Inc. are not responsible for the privacy policy of any third party Web sites. We encourage you to read the privacy policy of every Web site you visit. Click CANCEL to return or OK to continue.
OKCancel
The information requested is intended for US healthcare professionals only. I am a healthcare professionalI am not a healthcare professional
The requested information is provided in Portable Document Format (PDF). To view and print this document you'll need to install a copy of the free Adobe® Acrobat® Reader®. If you already have Adobe Acrobat Reader installed click "VIEW PDF" below. If you need the Acrobat Reader you can download it from the Adobe Acrobat Reader Download page.

View PDF Cancel

Don't show me this message again.

 

Do I Qualify for SUCCEED?

7-Question Survey

Can I take part in the SUCCEED trial?

Answer these quick questions to see if you may be eligible to take part in the SUCCEED trial.

1.
I have a diagnosis of metastatic soft-tissue or bone sarcoma.

2.
I have already completed at least one regimen of chemotherapy (at least 4 cycles).

3.
My doctor has informed me that I achieved a favorable outcome or stable disease, following at least my fourth cycle of chemotherapy.

4.
My last round of chemotherapy to treat my sarcoma occurred within the last 6 weeks.

5.
Apart from the sarcoma, I am generally in good health and do not have cardiovascular disease or any life-threatening illness or organ system dysfunction.

6.
I am 18 years of age or older.

7.
I am between the ages of 13 and 17 and weigh at least 100 pounds.

Back to Top



Home | Register for Updates | Contact Us | Privacy Policy | Terms of Use | Unsubscribe | Site Map

This site is intended for US residents only. The use of deforolimus (AP23573, MK-8669) is limited to investigational trials.
There is no guarantee that its use will be approved by the US Food and Drug Administration.

This site is brought to you by ARIAD Pharmaceuticals, Inc. and Merck & Co., Inc.
© 2008 ARIAD Pharmaceuticals, Inc.
Copyright © 2008 Merck & Co., Inc. All rights reserved.

ARIADMERCK